Ambev S.A. reports November 2025 treasury share movements

Ambev S.A. reported its own transactions in Ambev securities for November 2025, focusing on movements in treasury shares.

Rhea-AI Filing Summary

Ambev S.A. reported its own transactions in Ambev securities for November 2025, focusing on movements in treasury shares. The company started the month holding 169,171,789 common shares in treasury and no ADRs. During the month, it delivered 106,294 common shares as restricted shares at a reference price of R$12.91 per share, totaling R$1,372,255.54, and purchased 17,210 common shares directly from the company at R$13.77 per share, totaling R$236,981.70. After these transactions, Ambev ended November with 169,082,705 common shares in treasury and no ADRs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Ambev S.A. (ABEV) disclose in this November 2025 report?

Ambev S.A. disclosed its November 2025 transactions in its own securities, detailing treasury share deliveries for restricted shares and direct share purchases, along with initial and final treasury balances.

How many Ambev (ABEV) treasury shares were delivered as restricted shares in November 2025?

Ambev delivered 106,294 common shares as restricted shares in November 2025, at a reference price of R$12.91 per share, totaling R$1,372,255.54.

How many Ambev (ABEV) shares did the company purchase in November 2025?

The company purchased 17,210 common shares directly from the company on day 24 of November 2025 at R$13.77 per share, for a total of R$236,981.70.

What was Ambev’s (ABEV) final treasury share balance at the end of November 2025?

At the end of November 2025, Ambev held 169,082,705 common shares in treasury and no ADRs, compared with 169,171,789 common shares at the beginning of the month.

Does this Ambev (ABEV) disclosure involve ADR transactions?

No. The disclosure shows that Ambev had zero ADRs in treasury at both the beginning and end of November 2025, and no ADR transactions are listed.

Who signed this Ambev S.A. (ABEV) report?

The report was signed by Guilherme Fleury de Figueiredo Ferraz Parolari, who serves as Ambev’s Chief Financial and Investor Relations Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/09/2025 - 04:08 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of December, 2025

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 

Form 20-F ___X___ Form 40-F _______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. 

Yes _______ No ___X____

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In November 2025:

(X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002.⁽¹⁾

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.

Name: Ambev S.A.

CPF/CNPJ: 07.526.557/0001-00

Qualification: Outstanding Shares in Treasury

Initial Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

Shares

Common

169,171,789

ADR

Common

0.00

Transactions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day

Quantity

Price

Volume (R$)(3)

Shares

Common

Direct with company

Delivery of restricted shares

04

106,294

12.91

1,372,255.54

Shares

Common

Direct with company

Purchase

24

17,210

13.77

236,981.70

Final Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

Shares

Common

169,082,705

ADR

Common

0

(1) When filling in the form, delete the lines that do not have any information, If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information,

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others,

(3) Quantity multiplied by price,

(*) Each ADR is equivalent to 1 (one) share,

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: December 8, 2025

	AMBEV S.A.
	By:	/s/ Guilherme Fleury de Figueiredo Ferraz Parolari
		Guilherme Fleury de Figueiredo Ferraz Parolari Chief Financial and Investor Relations Officer